Cellular Therapies: Revolutionizing Cancer Therapy
Part 4: Adoptive Cell Therapy - Lessons Learned, Issues and the Future

 

Related Videos (117)

In this, the final video in this four-part series, Carl June, MD, reviews the challenges identified with CAR T cell therapy in the hematologic malignancies--including resistance and early relapse in some patients and toxicities (i.e., tumor lysis syndrome, cytokine release syndrome) --as well as the progress made to resolve or ameliorate these concerns and future considerations for the therapy.

To view other parts of this program:

Part 1: Adoptive Cell Therapy - An Introduction

Part 2: CTL019 Therapy in Chronic Lymphocytic Leukemia

Part 3: CTL019 in Relapsed Refractory Pediatric Acute Lymphoblastic Leukemia

 

Penn PhysicianLink®

Penn PhysicianLink® is an exclusive program that helps all referring physicians connect with Penn Medicine. This comprehensive package of support services expedites and facilitates direct physician communication for patient consults, referrals and transfers.

Learn more about Penn PhysicianLink®